'40-50 million doses of Covishield stockpiled': Serum Institute of India

Video Credit: ANI
Published on December 28, 2020 - Duration: 01:43s

'40-50 million doses of Covishield stockpiled': Serum Institute of India

Briefing about the status of coronavirus vaccine, Serum Institute of India CEO Adar Poonawalla informed that 40-50 million doses of Covishield have been stockpiled.

"We have 40-50 million doses of Covishield stockpiled.

Once we get regulatory approvals in a few days, it'll be down to the Govt to decide how much they can take and how fast.

We will be producing around 300 million doses by July 2021," said Adar Poonawalla.


You are here

Related news from verified sources

Adar Poonawalla, Chief Executive Officer, Serum Institute of India, said, "We will be producing around 300 million doses by July 2021," adding "The first six...
on December 28, 2020 • Zee News

Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. "As promised, before the...
on December 7, 2020 • Mid-Day

Related videos from verified sources

'India will get 50% of everything...': World's largest vaccine-maker, SII 02:53
Video credit: HT Digital Content - Published on December 29, 2020 

Harsh Vardhan launches India's 1st indigenous pneumonia vaccine 02:02
Video credit: ANI - Published on December 29, 2020 

'Will keep giving 50% of everything we make to India': SII's Adar Poonawalla 02:13
Video credit: ANI - Published on December 28, 2020 

You might like